Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature

Oncogene

Volumn 31, Issue 27, 2012, Pages 3298-3309

  Franks, S E ^a   Campbell, C I ^a   Barnett, E F ^a   Siwicky, M D ^a   Livingstone, J ^b   Cory, S ^b   Moorehead, R A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

claudin; DNA microarray; EMT; IGF IR; mammary tumor

Indexed keywords

CLAUDIN 3; CLAUDIN 4; CLAUDIN 7; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CANCER REGRESSION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CLAUDINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RECEPTOR, IGF TYPE 1; TRANSCRIPTOME; TRANSGENES;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS;

EID: 84863722180     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.486     Document Type: Article

References (29)

1. Adelaide J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F et al. (2007). Integrated profiling of basal and luminal breast cancers. Cancer Res 67: 11565-11575.
2. Fagan DH, Yee D. (2008). Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 13: 423-429.
3. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB et al. (2006). Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355: 560-569. (Pubitemid 44200649)
4. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S et al. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
5. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A et al. (2001). Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61: 5979-5984. (Pubitemid 32762524)
6. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z et al. (2007). Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8: R76.
7. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF et al. (2006). The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7: 96.
8. Huang F, Greer A, Hurlburt W, Han X, Hafezi R, Wittenberg GM et al. (2009). The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors. Cancer Res 69: 161-170.
9. Jones RA, Campbell CI, Gunther EJ, Chodosh LA, Petrik JJ, Khokha R et al. (2007). Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation. Oncogene 26: 1636-1644. (Pubitemid 46398739)
10. Jones RA, Campbell CI, Wood GA, Petrik JJ, Moorehead RA. (2009). Reversibility and recurrence of IGF-IR-induced mammary tumors. Oncogene 13: 407-413.
11. Klinakis A, Szabolcs M, Chen G, Xuan S, Hibshoosh H, Efstratiadis A. (2009). Igf1r as a therapeutic target in a mouse model of basallike breast cancer. Proc Natl Acad Sci USA 106: 2359-2364.
12. Koda M, Przystupa W, Jarzabek K, Wincewicz A, Kanczuga-Koda L, Tomaszewski J et al. (2005). Expression of insulin-like growth factor-I receptor, estrogen receptor alpha, Bcl-2 and Bax proteins in human breast cancer. Oncol Rep 14: 93-98.
13. Koda M, Sulkowski S, Garofalo C, Kanczuga-Koda L, Sulkowska M, Surmacz E. (2003). Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta. Horm Metab Res 35: 794-801. (Pubitemid 38058185)
14. Lanzino M, Morelli C, Garofalo C, Panno ML, Mauro L, Ando S et al. (2008). Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer. Curr Cancer Drug Targets 8: 597-610.
15. Lerma E, Peiro G, Ramon T, Fernandez S, Martinez D, Pons C et al. (2007). Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas). Mod Pathol 20: 1200-1207. (Pubitemid 47609069)
16. Maki RG. (2010). Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol 28: 4985-4995.
17. Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R et al. (2010). BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7: 403-417.
18. Perou CM, Sorlie T, Eisen MB, van de RM, Jeffrey SS, Rees CA et al. (2000). Molecular portraits of human breast tumours. Nature 406: 747-752.
19. Peyrat JP, Bonneterre J, Beuscart R, Djiane J, Demaille A. (1988). Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 48: 6429-6433.
20. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI et al. (2010). Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68.
21. Sarfstein R, Maor S, Reizner N, Abramovitch S, Werner H. (2006). Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer. Mol Cell Endocrinol 252: 241-246.
22. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874. (Pubitemid 32878711)
23. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418-8423. (Pubitemid 36842560)
24. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A et al. (2003). Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 100: 10393-10398. (Pubitemid 37071889)
25. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550. (Pubitemid 41528093)
26. van,t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536. (Pubitemid 34130608)
27. Werner H, Karnieli E, Rauscher FJ, LeRoith D. (1996). Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 93: 8318-8323. (Pubitemid 26269555)
28. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R et al. (2001). Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98: 11462-11467. (Pubitemid 32928751)
29. Yang J, Weinberg RA. (2008). Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829. (Pubitemid 351757205)